RE:RE:RE:RE:RE:RE:Exelon & HUGE GROWING UNMET NEEDAlways glad to help. Follow the following and if you sign up they will email you their BUY AND SELL day trade.
Currently I hold Surf, twist, CRSP, Repare. They do intensive research in the future disruptive biotech space. GUD HAD A GREAT CHANCE to get involved but they waisted millions and seven Years and no profits. The whole biotech industry has changed several times upside down but GUD MNGT does not know. Meir did but no one listens. BMY trades at 10 PE for they have low growth potential, GUD would need to make $.50 to justify their current $5.25 share price. It may take them another seven Years. GUD In 2022 expected profit $.010 per share.
ARK Genomic Revolution ETF